We are live on ! Find out more
CADL icon

Candel Therapeutics
CADL

114 hedge funds and large institutions have $213M invested in Candel Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

388% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 8

147% more call options, than puts

Call options by funds: $2.14M | Put options by funds: $869K

82% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 22

59% more capital invested

Capital invested by funds: $134M → $213M (+$79.4M)

36% more funds holding

Funds holding: 84 → 114 (+30)

16.24% more ownership

Funds ownership: 43.05% → 59.29% (+16%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
114
Holders Change
+30
Holders Change %
+35.71%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
39
Increased
40
Reduced
22
Closed
8
Calls
$2.14M
Puts
$869K
Net Calls
+$1.27M
Net Calls Change
-$205K

Top Buyers

1
RI
RTW Investments
New York
+$34.9M
2
SVCM
Saturn V Capital Management
Texas
+$15.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15M
4
PCM
Portolan Capital Management
Massachusetts
+$6.52M
5
VPC
Vestal Point Capital
New York
+$6.12M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$836K
2
Focus Partners Wealth
Focus Partners Wealth
Massachusetts
-$462K
3
Morgan Stanley
Morgan Stanley
New York
-$413K
4
Barclays
Barclays
United Kingdom
-$314K
5
Wells Fargo
Wells Fargo
California
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$53.8M +$15M +2,752,718 +33%
RI
2
RTW Investments
New York
$31.5M +$34.9M +6,422,018 New
ACA
3
Acorn Capital Advisors
New York
$17.2M +$4.99M +917,431 +36%
BlackRock
4
BlackRock
New York
$15.2M +$1.35M +247,353 +9%
SVCM
5
Saturn V Capital Management
Texas
$14.2M +$15.8M +2,896,588 New
PCM
6
Portolan Capital Management
Massachusetts
$14.2M +$6.52M +1,198,958 +71%
VCM
7
Vanguard Capital Management
Pennsylvania
$12.1M +$13.4M +2,462,757 New
VPC
8
Vestal Point Capital
New York
$5.51M +$6.12M +1,125,000 New
Millennium Management
9
Millennium Management
New York
$5.19M +$5.77M +1,060,086 New
Geode Capital Management
10
Geode Capital Management
Massachusetts
$5.07M +$315K +57,923 +6%
HFF
11
Halter Ferguson Financial
Indiana
$4.43M +$849K +155,996 +21%
State Street
12
State Street
Massachusetts
$4.01M +$143K +26,340 +3%
HCM
13
Heights Capital Management
California
$3.8M +$4.22M +775,000 New
SCV
14
Sands Capital Ventures
Virginia
$1.99M – – –
Northern Trust
15
Northern Trust
Illinois
$1.58M +$151K +27,716 +9%
VFT
16
Vanguard Fiduciary Trust
Pennsylvania
$1.37M +$1.53M +280,451 New
VPM
17
Vanguard Portfolio Management
Pennsylvania
$1.31M +$1.46M +268,249 New
Goldman Sachs
18
Goldman Sachs
New York
$1.11M +$884K +162,436 +250%
ECM
19
ExodusPoint Capital Management
New York
$1.11M +$1.24M +227,468 New
GCM
20
Ghisallo Capital Management
Massachusetts
$980K +$1.09M +200,000 New
KCM
21
Kynam Capital Management
New Jersey
$980K +$1.09M +200,000 New
TWM
22
Tanager Wealth Management
United Kingdom
$971K – – –
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$845K +$936K +171,978 New
WP
24
Woodline Partners
California
$768K +$853K +156,700 New
UBS Group
25
UBS Group
Switzerland
$734K +$248K +45,516 +44%
1
2 3 4 5

CADL Hedge Fund Activity: Q1 2026 in Review

114 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Candel Therapeutics (CADL) for Q1 2026, worth a combined $213M — up 59% from $134M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new CADL positions and 8 closed out — a net gain of 31 holders — while 40 added to existing stakes and 22 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $34.9M. The largest seller was Citadel Advisors, cutting an estimated $836K.

  • 114 institutional investors held Candel Therapeutics (CADL) as of Q1 2026, up from 84 in Q4 2025.
  • Funds reported $213M of Candel Therapeutics stock for Q1 2026, up 59% quarter-over-quarter.
  • 39 funds opened new Candel Therapeutics positions in Q1 2026 and 8 closed out, a net change of +31 holders.
  • The largest Candel Therapeutics buyer in Q1 2026 was RTW Investments, an estimated $34.9M added.
  • The largest Candel Therapeutics seller in Q1 2026 was Citadel Advisors, an estimated $836K sold.

Based on aggregated 13F filings for Q1 2026.